DS Healthcare Group Inc. a leading developer of personal care products, announced that it has developed and will launch an over-the-counter neutraceutical tablet to combat premature hair thinning and improve healthy hair growth.
Sold under the DS Laboratories brand, the tablet will complement and extend the company's industry-leading topical treatments, which promote longer, stronger, thicker hair.
The new DS Laboratories tablet will launch in Mexico during the first quarter of 2014. It will expand worldwide through the company's growing network of foreign markets.
DS Laboratories products already sell in more than 15 countries as part of a rapid global expansion.
The new oral supplement employs a novel approach within the thinning-hair category -- complex peptides with potent antioxidants -- to maximize efficacy and potency. This formula results from ongoing clinical research at DS Healthcare Group on hair loss and related conditions.
"We've developed our own proprietary tablet, which contains a unique composition of ingredients, to achieve a real breakthrough in neutraceutical research," stated DS Healthcare President and CEO Daniel Khesin.